Home › Companies › Perspective Therapeutics, Inc. › 2025-2026

Perspective Therapeutics, Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Perspective Therapeutics, Inc.’s Form 8-K, filed 2026-05-27 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 8Reported items
  • 140Asset managers
  • 1,092Fund votes
  • 2026-05-27Meeting date

Proxy season: 2024-2025 2025-2026

Explore Perspective Therapeutics, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Perspective Therapeutics, Inc.

These tallies are Perspective Therapeutics, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-05-27 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Perspective Therapeutics, Inc. — official shareholder meeting results, meeting held 2026-05-27
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
Elect Director: Lori A. Woods 69,622,536---- 7,660,68920,599,237 Majority: yes
Elect Director: Heidi Henson 74,298,922---- 2,984,30320,599,237 Majority: yes
Elect Director: Maya Martinez-Davis 77,085,447---- 197,77820,599,237 Majority: yes
Elect Director: Frank Morich, M.D., Ph.D. 62,317,819---- 14,965,40620,599,237 Majority: yes
Elect Director: Johan (Thijs) Spoor 77,090,696---- 192,52920,599,237 Majority: yes
Elect Director: Robert Froman Williamson, III 67,908,625---- 9,374,60020,599,237 Majority: yes
Proposal 2: The Auditor Ratification Proposal 97,636,978125,426120,058 ---- Majority: yes

Source: Perspective Therapeutics, Inc., Form 8-K, filed with the SEC on 2026-05-27 — read the filing on EDGAR.

How asset managers voted at the Perspective Therapeutics, Inc. 2025-2026 meeting

Each item below shows how the 140 asset managers that disclosed a Perspective Therapeutics, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Perspective Therapeutics, Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation of the Company's named executive officers.

SECTION 14A SAY-ON-PAY VOTES

Combines 4 wordings of this item as funds reported it.

100% fund support · no official result

ONE YEAR 59%1 YEAR 40%

The 136 asset managers below cast 100% of the shares they voted on this item FOR (97,627 for, 0 against).

FOR: 97,627 (0.3%)ABSTAIN: 2,991 (0.0%)ONE YEAR: 22,440,148 (59.0%)1 YEAR: 15,310,645 (40.3%)THREE YEARS: 172,175 (0.5%)1.0: 7,663 (0.0%)3 YEARS: 2,953 (0.0%)3.0: 1 (0.0%)
Largest asset managers voting on “To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the compensation o” at Perspective Therapeutics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Commodore Capital LP00 00One Year
Avidity Partners Management LP00 001 Year
Vanguard00 00One Year
BlackRock00 001 Year
State Street00 00One Year
Affinity Asset Advisors, LLC00 001 Year
BALYASNY ASSET MANAGEMENT L.P.00 001 Year
Charles Schwab00 001 Year
Fidelity00 00One Year
GEODE CAPITAL MANAGEMENT, LLC00 00One Year
Citadel00 00One Year
Hills Bank & Trust Co00 001 Year
Nuveen00 00One Year
TIAA00 00One Year
REGIONS FINANCIAL CORP00 00One Year
Voya00 00One Year
ADAR1 Capital Management, LLC00 00One Year
Invesco00 00One Year
Northern Trust00 001 Year
PORTLAND INVESTMENT COUNSEL INC.00 001 Year
Two Sigma00 00One Year
MELLON INVESTMENTS Corp00 00One Year
Federated Hermes00 001 Year
Dimensional00 00Three Years
Equitable00 00One Year

Showing the 25 largest of 136 asset managers. See all 136 in the interactive database.

2. Election of Directors: Frank Morich, M.D., Ph.D.

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

81% Majority: yes · of votes cast

FOR 81%WITHHELD 19%
FOR: 62,317,819WITHHELD: 14,965,406

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Frank Morich, M.D., Ph.D.”): 62,317,819 for, 14,965,406 withheld, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 114,046,197 outstanding shares: 54.6% for, 13% withheld (68% of the company cast a for/withheld vote).

The 43 asset managers below cast 100% of the shares they voted on this item FOR (9,943,267 for, 0 against).

FOR 82%ABSTAIN 18%
FOR: 9,943,267 (81.8%)ABSTAIN: 2,212,631 (18.2%)
Largest asset managers voting on “Election of Directors: Frank Morich, M.D., Ph.D.” at Perspective Therapeutics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard5,070,3350 3,6390For
BlackRock00 1,730,1050Abstain
State Street1,642,6400 00For
Fidelity865,2990 00For
TIAA777,6140 00For
Charles Schwab661,2730 00For
Voya213,7900 00For
Invesco00 203,3960Abstain
Dimensional169,1210 00For
Equitable48,7400 95,1400Abstain
BRIDGEWAY FUNDS INC89,5460 00For
Federated Hermes81,4910 00For
QUANTITATIVE MASTER SERIES LLC00 69,2420Abstain
ProShares50,5160 00For
Direxion Shares ETF Trust47,2290 00For
Lincoln Financial42,1000 00For
AIG/SunAmerica34,9860 00For
Northern Trust33,3090 00For
Global X00 28,1960Abstain
Bridge Builder Trust00 28,0630Abstain
Pacific Life00 23,6340Abstain
Brighthouse20,1370 00For
John Hancock16,6060 00For
Goldman Sachs15,6340 00For
Nationwide00 13,1040Abstain

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

3. Election of Directors: Heidi Henson

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

96% Majority: yes · of votes cast

FOR 96%
FOR: 74,298,922WITHHELD: 2,984,303

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Heidi Henson”): 74,298,922 for, 2,984,303 withheld, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 114,046,197 outstanding shares: 65% for, 3% withheld (68% of the company cast a for/withheld vote).

The 43 asset managers below cast 100% of the shares they voted on this item FOR (11,639,765 for, 0 against).

FOR 96%
FOR: 11,639,765 (95.8%)ABSTAIN: 516,133 (4.2%)
Largest asset managers voting on “Election of Directors: Heidi Henson” at Perspective Therapeutics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard5,073,9680 60For
BlackRock1,730,1050 00For
State Street1,640,7220 1,9180For
Fidelity865,2990 00For
TIAA777,6140 00For
Charles Schwab661,2730 00For
Voya213,7900 00For
Invesco203,3960 00For
Dimensional00 169,1210Abstain
Equitable143,8800 00For
BRIDGEWAY FUNDS INC00 89,5460Abstain
Federated Hermes81,4910 00For
QUANTITATIVE MASTER SERIES LLC69,2420 00For
ProShares00 50,5160Abstain
Direxion Shares ETF Trust00 47,2290Abstain
Lincoln Financial42,1000 00For
AIG/SunAmerica00 34,9860Abstain
Northern Trust00 33,3090Abstain
Global X28,1960 00For
Bridge Builder Trust28,0630 00For
Pacific Life23,6340 00For
Brighthouse00 20,1370Abstain
John Hancock00 16,6060Abstain
Goldman Sachs15,6340 00For
Nationwide12,3290 7750For

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

4. Election of Directors: Johan (Thijs) Spoor

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 77,090,696WITHHELD: 192,529

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Johan (Thijs) Spoor”): 77,090,696 for, 192,529 withheld, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 114,046,197 outstanding shares: 68% for, 0.2% withheld (68% of the company cast a for/withheld vote).

The 43 asset managers below cast 100% of the shares they voted on this item FOR (12,155,898 for, 0 against).

FOR 100%
FOR: 12,155,898 (100.0%)
Largest asset managers voting on “Election of Directors: Johan (Thijs) Spoor” at Perspective Therapeutics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard5,073,9740 00For
BlackRock1,730,1050 00For
State Street1,642,6400 00For
Fidelity865,2990 00For
TIAA777,6140 00For
Charles Schwab661,2730 00For
Voya213,7900 00For
Invesco203,3960 00For
Dimensional169,1210 00For
Equitable143,8800 00For
BRIDGEWAY FUNDS INC89,5460 00For
Federated Hermes81,4910 00For
QUANTITATIVE MASTER SERIES LLC69,2420 00For
ProShares50,5160 00For
Direxion Shares ETF Trust47,2290 00For
Lincoln Financial42,1000 00For
AIG/SunAmerica34,9860 00For
Northern Trust33,3090 00For
Global X28,1960 00For
Bridge Builder Trust28,0630 00For
Pacific Life23,6340 00For
Brighthouse20,1370 00For
John Hancock16,6060 00For
Goldman Sachs15,6340 00For
Nationwide13,1040 00For

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

5. Election of Directors: Lori A. Woods

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

90% Majority: yes · of votes cast

FOR 90%10%
FOR: 69,622,536WITHHELD: 7,660,689

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Lori A. Woods”): 69,622,536 for, 7,660,689 withheld, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 114,046,197 outstanding shares: 61% for, 7% withheld (68% of the company cast a for/withheld vote).

The 43 asset managers below cast 100% of the shares they voted on this item FOR (10,178,206 for, 0 against).

FOR 84%ABSTAIN 16%
FOR: 10,178,206 (83.7%)ABSTAIN: 1,977,692 (16.3%)
Largest asset managers voting on “Election of Directors: Lori A. Woods” at Perspective Therapeutics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard5,062,8360 11,1380For
BlackRock00 1,730,1050Abstain
State Street1,640,4100 2,2300For
Fidelity865,2990 00For
TIAA777,6140 00For
Charles Schwab661,2730 00For
Voya213,7900 00For
Invesco203,3960 00For
Dimensional169,1210 00For
Equitable48,7400 95,1400Abstain
BRIDGEWAY FUNDS INC89,5460 00For
Federated Hermes81,4910 00For
QUANTITATIVE MASTER SERIES LLC00 69,2420Abstain
ProShares50,5160 00For
Direxion Shares ETF Trust47,2290 00For
Lincoln Financial42,1000 00For
AIG/SunAmerica34,9860 00For
Northern Trust33,3090 00For
Global X28,1960 00For
Bridge Builder Trust00 28,0630Abstain
Pacific Life00 23,6340Abstain
Brighthouse20,1370 00For
John Hancock16,6060 00For
Goldman Sachs15,6340 00For
Nationwide7750 12,3290Abstain

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

6. Election of Directors: Maya Martinez-Davis

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

99.7% Majority: yes · of votes cast

FOR 99.7%
FOR: 77,085,447WITHHELD: 197,778

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Maya Martinez-Davis”): 77,085,447 for, 197,778 withheld, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 114,046,197 outstanding shares: 68% for, 0.2% withheld (68% of the company cast a for/withheld vote).

The 43 asset managers below cast 100% of the shares they voted on this item FOR (12,155,123 for, 0 against).

FOR 99.9%
FOR: 12,155,123 (100.0%)ABSTAIN: 775 (0.0%)
Largest asset managers voting on “Election of Directors: Maya Martinez-Davis” at Perspective Therapeutics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard5,073,9740 00For
BlackRock1,730,1050 00For
State Street1,642,6400 00For
Fidelity865,2990 00For
TIAA777,6140 00For
Charles Schwab661,2730 00For
Voya213,7900 00For
Invesco203,3960 00For
Dimensional169,1210 00For
Equitable143,8800 00For
BRIDGEWAY FUNDS INC89,5460 00For
Federated Hermes81,4910 00For
QUANTITATIVE MASTER SERIES LLC69,2420 00For
ProShares50,5160 00For
Direxion Shares ETF Trust47,2290 00For
Lincoln Financial42,1000 00For
AIG/SunAmerica34,9860 00For
Northern Trust33,3090 00For
Global X28,1960 00For
Bridge Builder Trust28,0630 00For
Pacific Life23,6340 00For
Brighthouse20,1370 00For
John Hancock16,6060 00For
Goldman Sachs15,6340 00For
Nationwide12,3290 7750For

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

7. Election of Directors: Robert Froman Williamson, III

DIRECTOR ELECTIONSMajority of the votes cast: yes

Combines 5 wordings of this item as funds reported it.

88% Majority: yes · of votes cast

FOR 88%12%
FOR: 67,908,625WITHHELD: 9,374,600

Perspective Therapeutics, Inc.’s own tally for this item (“Elect Director: Robert Froman Williamson, III”): 67,908,625 for, 9,374,600 withheld, per its Form 8-K filed 2026-05-27 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item. Of all 114,046,197 outstanding shares: 60% for, 8% withheld (68% of the company cast a for/withheld vote).

The 43 asset managers below cast 100% of the shares they voted on this item FOR (6,985,069 for, 0 against).

FOR 57%ABSTAIN 43%
FOR: 6,985,069 (57.5%)ABSTAIN: 5,170,829 (42.5%)
Largest asset managers voting on “Election of Directors: Robert Froman Williamson, III” at Perspective Therapeutics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard5,073,9570 170For
BlackRock00 1,730,1050Abstain
State Street3,4600 1,639,1800Abstain
Fidelity103,3000 761,9990Abstain
TIAA777,6140 00For
Charles Schwab661,2730 00For
Voya213,7900 00For
Invesco00 203,3960Abstain
Dimensional00 169,1210Abstain
Equitable00 143,8800Abstain
BRIDGEWAY FUNDS INC00 89,5460Abstain
Federated Hermes81,4910 00For
QUANTITATIVE MASTER SERIES LLC00 69,2420Abstain
ProShares00 50,5160Abstain
Direxion Shares ETF Trust00 47,2290Abstain
Lincoln Financial00 42,1000Abstain
AIG/SunAmerica00 34,9860Abstain
Northern Trust00 33,3090Abstain
Global X28,1960 00For
Bridge Builder Trust00 28,0630Abstain
Pacific Life00 23,6340Abstain
Brighthouse00 20,1370Abstain
John Hancock00 16,6060Abstain
Goldman Sachs15,6340 00For
Nationwide7750 12,3290Abstain

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

8. To ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the Company for the fiscal year ending December 31, 2026.

AUDIT-RELATED

Combines 2 wordings of this item as funds reported it.

100% fund support · no official result

FOR 100%

The 43 asset managers below cast 100% of the shares they voted on this item FOR (12,155,898 for, 0 against).

FOR: 12,155,898 (100.0%)
Largest asset managers voting on “To ratify the appointment of WithumSmith+Brown, PC as the independent registered public accounting firm of the” at Perspective Therapeutics, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Vanguard5,073,9740 00For
BlackRock1,730,1050 00For
State Street1,642,6400 00For
Fidelity865,2990 00For
TIAA777,6140 00For
Charles Schwab661,2730 00For
Voya213,7900 00For
Invesco203,3960 00For
Dimensional169,1210 00For
Equitable143,8800 00For
BRIDGEWAY FUNDS INC89,5460 00For
Federated Hermes81,4910 00For
QUANTITATIVE MASTER SERIES LLC69,2420 00For
ProShares50,5160 00For
Direxion Shares ETF Trust47,2290 00For
Lincoln Financial42,1000 00For
AIG/SunAmerica34,9860 00For
Northern Trust33,3090 00For
Global X28,1960 00For
Bridge Builder Trust28,0630 00For
Pacific Life23,6340 00For
Brighthouse20,1370 00For
John Hancock16,6060 00For
Goldman Sachs15,6340 00For
Nationwide13,1040 00For

Showing the 25 largest of 43 asset managers. See all 43 in the interactive database.

Largest Perspective Therapeutics, Inc. shareholders voting in 2025-2026

Ranked by the number of Perspective Therapeutics, Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 114,046,197 shares outstanding at the time of that meeting.

Top Perspective Therapeutics, Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Commodore Capital LP 5.56%
2Avidity Partners Management LP 5.07%
3Vanguard 5.01%
4BlackRock 2.50%
5State Street 1.97%
6Affinity Asset Advisors, LLC 1.65%
7BALYASNY ASSET MANAGEMENT L.P. 1.32%
8Charles Schwab 1.16%
9Fidelity 0.90%
10GEODE CAPITAL MANAGEMENT, LLC 0.79%

Reported Perspective Therapeutics, Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Perspective Therapeutics, Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Lantheus Holdings, Inc. 7.66% 13D
Chen Yu 6.94% 13G
Qatar Investment Authority 6.20% 13G
Avidity Partners Management LP 5.30% 13G
BlackRock 4.69% 13F
Morgan Stanley 3.92% 13F
Millennium Management 3.55% 13F
Citadel Advisors 3.19% 13F
Vanguard Group 3.06% 13F
State Street 2.75% 13F

Percentages above are of 114,046,197 shares outstanding, as reported by Perspective Therapeutics, Inc. on its Form 10-Q dated 2026-05-06 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Perspective Therapeutics, Inc.’s 10-Q dated 2026-05-06. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Perspective Therapeutics, Inc.'s shareholder meeting held 2026-05-27, in the 2025-2026 proxy season, 140 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,092 separate fund positions. Their filings are grouped here into 8 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Perspective Therapeutics, Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on a non-binding advisory basis, the frequency of advisory stockholder votes on the… — the reporting funds cast 100% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Perspective Therapeutics, Inc. proxy season coverage: 2024-2025 · 2025-2026 (this page).